Logo image of RBLX

ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis

NYSE:RBLX - New York Stock Exchange, Inc. - US7710491033 - Common Stock - Currency: USD

74.09  +5.09 (+7.38%)

After market: 73.91 -0.18 (-0.24%)

Fundamental Rating

4

Overall RBLX gets a fundamental rating of 4 out of 10. We evaluated RBLX against 72 industry peers in the Entertainment industry. The financial health of RBLX is average, but there are quite some concerns on its profitability. While showing a medium growth rate, RBLX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

RBLX had negative earnings in the past year.
In the past year RBLX had a positive cash flow from operations.
In the past 5 years RBLX always reported negative net income.
RBLX had a positive operating cash flow in each of the past 5 years.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

RBLX has a Return On Assets of -13.04%. This is in the lower half of the industry: RBLX underperforms 65.28% of its industry peers.
With a Return On Equity value of -422.40%, RBLX is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -13.04%
ROE -422.4%
ROIC N/A
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 77.76%, RBLX belongs to the top of the industry, outperforming 90.28% of the companies in the same industry.
RBLX's Gross Margin has been stable in the last couple of years.
RBLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

6

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RBLX has been increased compared to 1 year ago.
Compared to 5 years ago, RBLX has more shares outstanding
Compared to 1 year ago, RBLX has an improved debt to assets ratio.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.27 indicates that RBLX is not in any danger for bankruptcy at the moment.
RBLX has a better Altman-Z score (3.27) than 80.56% of its industry peers.
The Debt to FCF ratio of RBLX is 1.57, which is an excellent value as it means it would take RBLX, only 1.57 years of fcf income to pay off all of its debts.
RBLX has a better Debt to FCF ratio (1.57) than 84.72% of its industry peers.
RBLX has a Debt/Equity ratio of 4.54. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RBLX (4.54) is worse than 70.83% of its industry peers.
Even though the debt/equity ratio score it not favorable for RBLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF 1.57
Altman-Z 3.27
ROIC/WACCN/A
WACC8.85%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.02 indicates that RBLX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.02, RBLX is in line with its industry, outperforming 58.33% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that RBLX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.02, RBLX is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.57% over the past year.
RBLX shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.68%.
RBLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 47.93% yearly.
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
Revenue 1Y (TTM)28.68%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%

3.2 Future

The Earnings Per Share is expected to grow by 11.76% on average over the next years. This is quite good.
The Revenue is expected to grow by 16.51% on average over the next years. This is quite good.
EPS Next Y-5.8%
EPS Next 2Y6.37%
EPS Next 3Y11.76%
EPS Next 5YN/A
Revenue Next Year20.98%
Revenue Next 2Y20.42%
Revenue Next 3Y19.04%
Revenue Next 5Y16.51%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

1

4. Valuation

4.1 Price/Earnings Ratio

RBLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RBLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of RBLX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 78.19
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.37%
EPS Next 3Y11.76%

0

5. Dividend

5.1 Amount

No dividends for RBLX!.
Industry RankSector Rank
Dividend Yield N/A

ROBLOX CORP -CLASS A

NYSE:RBLX (5/2/2025, 8:19:30 PM)

After market: 73.91 -0.18 (-0.24%)

74.09

+5.09 (+7.38%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners77.02%
Inst Owner Change0.31%
Ins Owners5.75%
Ins Owner Change0.56%
Market Cap50.14B
Analysts75.38
Price Target67.97 (-8.26%)
Short Float %2.34%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.94%
Min EPS beat(2)13.59%
Max EPS beat(2)28.29%
EPS beat(4)4
Avg EPS beat(4)20.5%
Min EPS beat(4)13.59%
Max EPS beat(4)28.29%
EPS beat(8)6
Avg EPS beat(8)11.79%
EPS beat(12)7
Avg EPS beat(12)-0.2%
EPS beat(16)8
Avg EPS beat(16)-45.05%
Revenue beat(2)1
Avg Revenue beat(2)2.8%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)8.2%
Revenue beat(4)2
Avg Revenue beat(4)1.99%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)8.2%
Revenue beat(8)3
Avg Revenue beat(8)0.81%
Revenue beat(12)3
Avg Revenue beat(12)-6.97%
Revenue beat(16)3
Avg Revenue beat(16)-12.59%
PT rev (1m)-0.12%
PT rev (3m)20.09%
EPS NQ rev (1m)0.5%
EPS NQ rev (3m)10.43%
EPS NY rev (1m)0.5%
EPS NY rev (3m)-5.19%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.92
P/FCF 78.19
P/OCF 60.98
P/B 226.43
P/tB 1099.48
EV/EBITDA N/A
EPS(TTM)-1.31
EYN/A
EPS(NY)-1.23
Fwd EYN/A
FCF(TTM)0.95
FCFY1.28%
OCF(TTM)1.22
OCFY1.64%
SpS5.32
BVpS0.33
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.04%
ROE -422.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.76%
FCFM 17.8%
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 4.54
Debt/FCF 1.57
Debt/EBITDA N/A
Cap/Depr 79.94%
Cap/Sales 5.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 3.27
F-Score6
WACC8.85%
ROIC/WACCN/A
Cap/Depr(3y)189.75%
Cap/Depr(5y)192.24%
Cap/Sales(3y)12.06%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
EPS Next Y-5.8%
EPS Next 2Y6.37%
EPS Next 3Y11.76%
EPS Next 5YN/A
Revenue 1Y (TTM)28.68%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%
Revenue Next Year20.98%
Revenue Next 2Y20.42%
Revenue Next 3Y19.04%
Revenue Next 5Y16.51%
EBIT growth 1Y15.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.43%
EBIT Next 3Y52.61%
EBIT Next 5Y35.29%
FCF growth 1Y417.12%
FCF growth 3Y4.75%
FCF growth 5Y113.37%
OCF growth 1Y79.47%
OCF growth 3Y7.65%
OCF growth 5Y52.65%